Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

Simone H. J. van den Elsen; Onno W. Akkerman; Erwin M. Jongedijk; Mireille Wessels; Samiksha Ghimire; Tjip S. van der Werf; Daan J. Touw; Mathieu S. Bolhuis; Jan-Willem C. Alffenaar

doi:10.1183/13993003.01903-2019

Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

Simone H. J. van den Elsen, Onno W. Akkerman, Erwin M. Jongedijk, Mireille Wessels, Samiksha Ghimire, Tjip S. van der Werf, Daan J. Touw, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar^*

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

5 Citaten (Scopus)

43 Downloads (Pure)

Originele taal-2	English
Artikelnummer	1901903
Aantal pagina's	4
Tijdschrift	European Respiratory Journal
Volume	55
Nummer van het tijdschrift	5
Vroegere onlinedatum	24-jan-2020
DOI's	https://doi.org/10.1183/13993003.01903-2019
Status	Published - 1-mei-2020

Toegang tot document

10.1183/13993003.01903-2019

Therapeutic drug monitoring using saliva as matrix_ an opportunity for linezolid, but challenge for moxifloxacinFinal author's version, 405 KBLicentie: Unspecified

Citeer dit

van den Elsen, S. H. J., Akkerman, O. W., Jongedijk, E. M., Wessels, M., Ghimire, S., van der Werf, T. S., Touw, D. J., Bolhuis, M. S., & Alffenaar, J-W. C. (2020). Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin. European Respiratory Journal, 55(5), [1901903]. https://doi.org/10.1183/13993003.01903-2019

van den Elsen, Simone H. J. ; Akkerman, Onno W. ; Jongedijk, Erwin M. ; Wessels, Mireille ; Ghimire, Samiksha ; van der Werf, Tjip S. ; Touw, Daan J. ; Bolhuis, Mathieu S. ; Alffenaar, Jan-Willem C. / Therapeutic drug monitoring using saliva as matrix : an opportunity for linezolid, but challenge for moxifloxacin. In: European Respiratory Journal. 2020 ; Vol. 55, Nr. 5.

@article{eba1278514c3462582f2a1caeb95bb0c,

title = "Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin",

keywords = "TUBERCULOSIS, FLUID, TB",

author = "{van den Elsen}, {Simone H. J.} and Akkerman, {Onno W.} and Jongedijk, {Erwin M.} and Mireille Wessels and Samiksha Ghimire and {van der Werf}, {Tjip S.} and Touw, {Daan J.} and Bolhuis, {Mathieu S.} and Alffenaar, {Jan-Willem C.}",

year = "2020",

month = may,

day = "1",

doi = "10.1183/13993003.01903-2019",

language = "English",

volume = "55",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",

number = "5",

}

Therapeutic drug monitoring using saliva as matrix : an opportunity for linezolid, but challenge for moxifloxacin. / van den Elsen, Simone H. J.; Akkerman, Onno W.; Jongedijk, Erwin M.; Wessels, Mireille ; Ghimire, Samiksha ; van der Werf, Tjip S.; Touw, Daan J.; Bolhuis, Mathieu S.; Alffenaar, Jan-Willem C.

In: European Respiratory Journal, Vol. 55, Nr. 5, 1901903, 01.05.2020.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Therapeutic drug monitoring using saliva as matrix

T2 - an opportunity for linezolid, but challenge for moxifloxacin

AU - van den Elsen, Simone H. J.

AU - Akkerman, Onno W.

AU - Jongedijk, Erwin M.

AU - Wessels, Mireille

AU - Ghimire, Samiksha

AU - van der Werf, Tjip S.

AU - Touw, Daan J.

AU - Bolhuis, Mathieu S.

AU - Alffenaar, Jan-Willem C.

PY - 2020/5/1

Y1 - 2020/5/1

KW - TUBERCULOSIS

KW - FLUID

KW - TB

U2 - 10.1183/13993003.01903-2019

DO - 10.1183/13993003.01903-2019

M3 - Letter

C2 - 31980497

VL - 55

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 5

M1 - 1901903

ER -